BOT 2.60% 39.5¢ botanix pharmaceuticals ltd

Bot Chart, page-9272

  1. 11,849 Posts.
    lightbulb Created with Sketch. 6005
    The Value in Biotech and Baby Pharma is the Science.

    IP is for Market Protection

    Licensing is for Revenue.. $$$

    The Science is not in question at BOT , meeting a few FDA Instruction Regulations is a walk in the park ,plus it's not BOT Management carrying out the task , It's one of the United States leading Law firms that is orchestrating the next meeting and submitting the instructions for approval.

    No One ever wants to have to take a backward step during the application process but as its a Milestone Gateway application process, it was only the Instructions that denied the approval..

    Regrettable and highly embarrassing for BOT Management , Mistakes happen , it's the remediation that counts...

    This Christmas period is going to be brutal across the ASX , I don't believe anyone is insulated from the sell down later this year,, NZT


 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
39.5¢
Change
0.010(2.60%)
Mkt cap ! $714.9M
Open High Low Value Volume
39.0¢ 40.5¢ 37.5¢ $4.833M 12.29M

Buyers (Bids)

No. Vol. Price($)
5 511746 39.0¢
 

Sellers (Offers)

Price($) Vol. No.
39.5¢ 99994 1
View Market Depth
Last trade - 16.10pm 17/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.